Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Ginseng is widely marketed as a cure-all, but the science tells a more nuanced story. Evidence is most promising for cancer-related fatigue, with modest signals for memory and respiratory infections — but it falls short for diabetes, heart disease, and cognitive decline. Clinicians should also watch for drug interactions, especially with warfarin and glucose-lowering medications.
Ginseng has been used medicinally for centuries, but a closer look at the evidence reveals a significant gap between its popular reputation and clinical reality. The term "ginseng" covers multiple species and a wide range of preparations — meaning results from one product can't necessarily be applied to another. Its active compounds, called ginsenosides, show anti-inflammatory, antioxidant, and immunomodulatory effects in lab studies, but translating those findings to real-world human benefit is a different story.
Across the most commonly claimed uses — fatigue, physical performance, cognition, immune support, blood sugar control, and cardiovascular health — the evidence is generally modest, inconsistent, and hampered by small, heterogeneous studies. The strongest signal comes from cancer-related fatigue, where some standardized preparations may offer limited benefit. For memory, there are small but statistically significant effects. For everything else, the data doesn't yet support routine recommendations.
Key Takeaways:
Why it matters: As patients increasingly turn to supplements, clinicians need accurate, evidence-based guidance on ginseng — both its limited potential benefits and its real safety risks.
